ANGPT2

angiopoietin 2, the group of Fibrinogen C domain containing|Receptor ligands

Basic information

Region (hg38): 8:6499632-6563409

Links

ENSG00000091879NCBI:285OMIM:601922HGNC:485Uniprot:O15123AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • lymphatic malformation 10 (Limited), mode of inheritance: Unknown

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Lymphatic malformation 10ADAllergy/Immunology/InfectiousThe condition involves lymphatic malformations, and in some individuals, progression to cellulitis has been reported, such that awareness may allow prompt treatment of infectious sequelaeAllergy/Immunology/Infectious; Cardiovascular32908006

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ANGPT2 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ANGPT2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
7
clinvar
4
clinvar
11
missense
22
clinvar
2
clinvar
4
clinvar
28
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
1
clinvar
8
clinvar
32
clinvar
6
clinvar
47
Total 0 1 30 41 14

Variants in ANGPT2

This is a list of pathogenic ClinVar variants found in the ANGPT2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
8-6499644-G-A Likely benign (Feb 05, 2019)1183190
8-6499670-T-C Benign (Jul 03, 2018)1251032
8-6499686-A-G Likely benign (Jul 15, 2018)1187061
8-6499714-A-T Benign (Jun 26, 2018)1262416
8-6499750-C-T Likely benign (Jan 16, 2019)1199699
8-6499786-T-C Benign (Jun 26, 2018)1175465
8-6499833-C-G Likely benign (Jul 13, 2023)2743017
8-6499833-C-T Likely benign (Dec 26, 2023)2777251
8-6499836-G-A Likely benign (Nov 08, 2023)2972971
8-6499839-G-C Likely benign (Nov 17, 2023)1531936
8-6499839-G-T Likely benign (Nov 06, 2023)2959443
8-6499841-G-A Likely benign (Jan 03, 2024)2753854
8-6499843-C-T Likely benign (Dec 25, 2023)1581965
8-6499845-C-T Microcephaly 1, primary, autosomal recessive Conflicting classifications of pathogenicity (Jan 19, 2024)908100
8-6499852-G-T Uncertain significance (Dec 01, 2019)870707
8-6499857-A-G Likely benign (Oct 04, 2023)2987487
8-6499860-G-A Microcephaly 1, primary, autosomal recessive • Intellectual disability • MCPH1-related disorder • Autosomal recessive primary microcephaly Conflicting classifications of pathogenicity (Apr 04, 2023)285523
8-6499870-T-C Likely benign (Aug 20, 2023)2787902
8-6499875-T-A Likely benign (Aug 04, 2023)2957761
8-6499893-G-A Likely benign (Jan 15, 2023)2827242
8-6499895-C-T Microcephaly 1, primary, autosomal recessive • Intellectual disability;Short stature • Inborn genetic diseases Conflicting classifications of pathogenicity (Dec 01, 2023)194122
8-6499896-G-A Likely benign (May 01, 2024)3003253
8-6499899-C-T Likely benign (Jan 29, 2024)2986540
8-6499904-T-A Inborn genetic diseases Uncertain significance (Oct 26, 2022)1502904
8-6499910-A-C Inborn genetic diseases Uncertain significance (Jun 06, 2023)2570461

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ANGPT2protein_codingprotein_codingENST00000325203 963759
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.8320.1681257370111257480.0000437
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.5272982731.090.00001453308
Missense in Polyphen74107.570.687941285
Synonymous-2.151301021.270.00000629848
Loss of Function4.02527.90.1790.00000127329

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.00005440.0000544
Finnish0.00004620.0000462
European (Non-Finnish)0.00007040.0000703
Middle Eastern0.00005440.0000544
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Binds to TEK/TIE2, competing for the ANGPT1 binding site, and modulating ANGPT1 signaling. Can induce tyrosine phosphorylation of TEK/TIE2 in the absence of ANGPT1. In the absence of angiogenic inducers, such as VEGF, ANGPT2-mediated loosening of cell-matrix contacts may induce endothelial cell apoptosis with consequent vascular regression. In concert with VEGF, it may facilitate endothelial cell migration and proliferation, thus serving as a permissive angiogenic signal. {ECO:0000269|PubMed:15284220, ECO:0000269|PubMed:19116766, ECO:0000269|PubMed:19223473, ECO:0000269|PubMed:9204896}.;
Pathway
PI3K-Akt signaling pathway - Homo sapiens (human);Kaposi,s sarcoma-associated herpesvirus infection - Homo sapiens (human);HIF-1 signaling pathway - Homo sapiens (human);Rap1 signaling pathway - Homo sapiens (human);Ras signaling pathway - Homo sapiens (human);MAPK signaling pathway - Homo sapiens (human);Rac1-Pak1-p38-MMP-2 pathway;Photodynamic therapy-induced HIF-1 survival signaling;Hypothesized Pathways in Pathogenesis of Cardiovascular Disease;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;PI3K-Akt Signaling Pathway;Tie2 Signaling;Cell surface interactions at the vascular wall;Hemostasis;Angiopoietin receptor Tie2-mediated signaling (Consensus)

Recessive Scores

pRec
0.107

Intolerance Scores

loftool
0.230
rvis_EVS
-0.42
rvis_percentile_EVS
25.73

Haploinsufficiency Scores

pHI
0.435
hipred
Y
hipred_score
0.824
ghis
0.507

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.857

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Angpt2
Phenotype
respiratory system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype; digestive/alimentary phenotype; homeostasis/metabolism phenotype; immune system phenotype; cellular phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);

Zebrafish Information Network

Gene name
angpt2b
Affected structure
subintestinal vein
Phenotype tag
abnormal
Phenotype quality
decreased length

Gene ontology

Biological process
angiogenesis;response to hypoxia;signal transduction;germ cell development;response to radiation;response to mechanical stimulus;response to glucose;negative regulation of cell-substrate adhesion;response to organic cyclic compound;response to activity;negative regulation of angiogenesis;animal organ regeneration;negative regulation of blood vessel endothelial cell migration;positive regulation of angiogenesis;Tie signaling pathway;leukocyte migration;negative regulation of positive chemotaxis;maternal process involved in female pregnancy;cellular response to growth factor stimulus;glomerulus vasculature development
Cellular component
extracellular region;extracellular space;nucleus;plasma membrane;cell projection
Molecular function
signaling receptor binding;protein binding;receptor tyrosine kinase binding;metal ion binding